Advancing Insights into Inborn Errors of Metabolism; Diagnosis and Therapeutics

Aqsa Mehreen, Khadija Tariq, Hawaida Ahmad, Imran Khan Yousafzai, Nayab Ahsan , Javeria Kulsoom, Haider Ali, Aroosa Imtiaz Khan, Zahra Robab

Abstract


The diverse group of rare and complex genetically inherited disorders known as inborn errors of metabolism are

typically caused by enzymes in various biochemical metabolic pathways of proteins, fats, and carbohydrates not being active.

This impairs organelle function, causes toxic substances to build up in cells, and disrupts the body's energy availability, all of

which can lead to complex medical conditions that can be fatal. From the early stages of the illness to puberty, the age at which

IEM is clinically represented can change. The estimated global incidence of inborn errors of metabolism is approximately 50.9

cases per 100,000 live births with a higher regional incidence in the east Mediterranean region. However, a recently published

study claims the incidence of IEM to be 1 case per 891 cases which can e translated to 112 in 100,000 cases. Inborn errors of

metabolism are complex disorders that are often misdiagnosed due to a lack of familiarity and understanding among medical

professionals. The increasing detection rates of IEM, driven by advancements in diagnostic methods, highlight the growing

need for medical professionals to develop a deeper knowledge of their early clinical symptoms. This understanding is crucial

for timely diagnosis and effective treatment. The following article offers a thorough assessment of the prevalent clinical

symptoms of IEM for the diagnosis, clinical and laboratory findings, and treatment of such illnesses. Lastly, it also emphasizes

that IEM is not a rare condition as the outdated notion of it suggests. The article may help to avoid misdiagnosis by medical

professionals.


Full Text:

PDF

Refbacks

  • There are currently no refbacks.


International Journal of Basic Medical Sciences and Pharmacy (IJBMSP): ISSN: 2049-4963